ERBB2 and breast carcinoma: The presence of HER2 in the plasma EVs of patients with breast cancer has been reported [63]; additionally, the study conducted in 2016 by Sina et al. [64] showed that in small EVs from women diagnosed with breast cancer, 14 to 35% were enriched with HER2.